LEA
ABBV icon

Legacy Edge Advisors’s AbbVie ABBV Stock Holding History

Legacy Edge Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Sell
5,386
-6
-0.1% -$1.29K 0.12% 89
2026
Q1 		$1.17M Sell
5,392
-146
-3% -$32.4K 0.12% 89
2025
Q4 		$1.27M Sell
5,538
-76
-1% -$17.3K 0.14% 85
2025
Q3 		$1.3M Sell
5,614
-101
-2% -$20.6K 0.15% 81
2025
Q2 		$1.06M Buy
5,715
+118
+2% +$21.9K 0.14% 81
2025
Q1 		$1.17M Sell
5,597
-3
-0.1% -$583 0.18% 63
2024
Q4 		$987K Sell
5,600
-105
-2% -$19.3K 0.16% 72
2024
Q3 		$1.13M Buy
5,705
+552
+11% +$103K 0.18% 67
2024
Q2 		$884K Buy
5,153
+366
+8% +$60.6K 0.16% 76
2024
Q1 		$872K Sell
4,787
-54
-1% -$9.31K 0.18% 72
2023
Q4 		$750K Buy
+4,841
New +$706K 0.17% 80

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Legacy Edge Advisors's ABBV Position: Q2 2026 in Review

Legacy Edge Advisors reduced its AbbVie (ABBV) stake by 0.11% in Q2 2026, selling an estimated $1.29K and leaving 5,386 shares worth $1.36M. The position accounts for 0.12% of the portfolio, ranked #89.

Legacy Edge Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,232 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Legacy Edge Advisors held 5,386 shares of AbbVie worth $1.36M as of Q2 2026.
  • Legacy Edge Advisors sold 6 AbbVie shares in Q2 2026, an estimated $1.29K.
  • AbbVie made up 0.12% of Legacy Edge Advisors's portfolio in Q2 2026, its #89 holding.
  • Legacy Edge Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,232 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Legacy Edge Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.